Article
Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Sept 2008
Riely Gregory J, Kris Mark G, Rosenbaum Daniel, Marks Jenifer, Li Allan, Chitale Dhananjay A, Nafa Khedoudja, Riedel Elyn R, Hsu Meier, Pao William, Miller Vincent A, Ladanyi Marc
Abstract excerpt
PURPOSE: KRAS mutations are found in approximately 25% of lung adenocarcinomas in Western countries and, as a group, have been strongly associated with cigarette smoking. These mutations are predictive of poor prognosis in resected disease as well as resistance to treatment with erlotinib or gefitinib. EXPERIMENTAL DESIGN: We determined the frequency and type of KRAS codon 12 and 13 mutations and characterized...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
